The Czech competition authority has approved the acquisition of Kardiologie na Bulovce by Nemocnice AGEL Třinec-Podlesí a.s. through a simplified procedure. This merger involves the provision of outpatient and inpatient healthcare services, particularly in internal medicine and cardiology.

Nemocnice AGEL Třinec is part of the AGEL business group, which operates in the Czech Republic across various healthcare sectors, including outpatient and inpatient care, pharmaceutical distribution, and diagnostic activities. The group is also involved in education, science, and research.

Kardiologie na Bulovce operates a healthcare facility in Prague, focusing on specialized cardiology services complemented by related specialties. The competition authority concluded that the merger would not lead to a significant distortion of competition, and the decision is final.